MusclePharm Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. MusclePharm last-minute Real Value cannot be determined due to lack of data. The latest price of MusclePharm is USD0.0. Our model forecasts the value of MusclePharm from analyzing the firm fundamentals such as Net Income of (12.87 M), revenue of 50.04 M, and Total Asset of 11.21 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that MusclePharm's price fluctuation is out of control at this time. Calculation of the real value of MusclePharm is based on 3 months time horizon. Increasing MusclePharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
MusclePharm's intrinsic value may or may not be the same as its current market price of 0.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 | Naive 1.27E-4 |
The intrinsic value of MusclePharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MusclePharm's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MusclePharm helps investors to forecast how MusclePharm pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MusclePharm more accurately as focusing exclusively on MusclePharm's fundamentals will not take into account other important factors: MusclePharm Total Value Analysis
MusclePharm is now projected to have takeover price of 0 with market capitalization of 0, debt of 10.71 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MusclePharm fundamentals before making investing decisions based on enterprise value of the companyMusclePharm Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of MusclePharm connotes not a very effective usage of assets in December.MusclePharm Profitability Analysis
The company reported the revenue of 50.04 M. Net Loss for the year was (12.87 M) with profit before overhead, payroll, taxes, and interest of 0.About MusclePharm Valuation
The pink sheet valuation mechanism determines MusclePharm's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of MusclePharm based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of MusclePharm. We calculate exposure to MusclePharm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MusclePharm's related companies.8 Steps to conduct MusclePharm's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates MusclePharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MusclePharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain MusclePharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine MusclePharm's revenue streams: Identify MusclePharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research MusclePharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish MusclePharm's growth potential: Evaluate MusclePharm's management, business model, and growth potential.
- Determine MusclePharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MusclePharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
MusclePharm Growth Indicators
Investing in growth stocks can be very risky. If the company such as MusclePharm does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 41.2 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in MusclePharm Pink Sheet
If you are still planning to invest in MusclePharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MusclePharm's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |